Utility of routine PET imaging to predict response and survival after induction therapy for non-small cell lung cancer Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Neoplasm Staging
  • Positron-Emission Tomography

abstract

  • An increase in glucose avidity of non-small cell lung cancers during induction therapy was associated with a worse prognosis compared with stable or any decrease in standardized uptake value. Changes in the glucose avidity of mediastinal nodal metastases may be a stronger predictor of survival than changes in the primary site of disease.

publication date

  • March 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4837652

Digital Object Identifier (DOI)

  • 10.1016/j.athoracsur.2015.09.099

PubMed ID

  • 26794896

Additional Document Info

start page

  • 1052

end page

  • 9

volume

  • 101

number

  • 3